Exchange: NASDAQ·Updated 07:14 PM EDT
MBRX logo

MBRX Moleculin Biotech Inc

$0.5238
$0.2529
(32.71%)
Today
Closed $0.5202
$0.0036
(0.69%)
After Hours
Mkt Cap$15.06M
Vol4.11M

About MBRX

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.
22

Extremely Bearish Sentiment

How do you feel about MBRX?

Advertisement|Remove ads.